The stock of Aphria Inc (CVE:APH) is a huge mover today! About 1.42 million shares traded hands. Aphria Inc (CVE:APH) has risen 6.00% since September 17, 2016 and is uptrending. It has outperformed by 0.39% the S&P500.
The move comes after 8 months positive chart setup for the $365.73M company. It was reported on Oct, 17 by Barchart.com. We have $6.31 PT which if reached, will make CVE:APH worth $263.33 million more.
More notable recent Aphria Inc (CVE:APH) news were published by: Midasletter.com which released: “Aphria Inc. CEO Vic Neufeld on Canopy Growth, Organigram and Recreational …” on November 10, 2015, also Seekingalpha.com with their article: “Aphria: A Growing Green Gem” published on August 22, 2016, Seekingalpha.com published: “The Most Compelling Marijuana Investment: Aphria” on June 01, 2016. More interesting news about Aphria Inc (CVE:APH) were released by: Marketwired.com and their article: “Aphria Inc. Announces $25 Million Bought Deal” published on July 28, 2016 as well as Midasletter.com‘s news article titled: “TSX Best Marijuana Bets in 2016: Canopy Growth Corp, Aphria Inc, and …” with publication date: January 02, 2016.
Aphria Inc., formerly Black Sparrow Capital Corp., is a Canada company, which is engaged in producing and selling medical marijuana through retail sales and wholesale channels. The company has a market cap of $365.73 million. The Company’s retail sales are primarily sold through the Company’s online store, as well as telephone orders. It has a 880.1 P/E ratio. The Company’s wholesale shipments are sold to other Medical Purposes Regulations Licensed Producers.
APH Company Profile
Amphenol Corporation (Amphenol), incorporated on December 19, 1986, is a designer, maker and marketer of electrical, electronic and fiber optic connectors, interconnect systems, antennas, sensors and sensor products, and coaxial and specialty cable. The Firm operates through two divisions: Interconnect Products and Assemblies, and Cable Products and Solutions.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.